CMR Surgical receives U.S. FDA Marketing Authorization for next-generation Versius Surgical System

The U.S. Food and Drug Administration (FDA) has granted CMR Surgical marketing authorization for the Versius Surgical System (Versius) in cholecystectomy, paving the way for the next-generation versatile, adaptable, and digitally driven surgical robot to be introduced in the United States.